Cited by 42HIV Research and TreatmentT-cell and Retrovirus StudiesHIV/AIDS drug development and treatment

Ezrin Is a Component of the HIV-1 Virological Presynapse and Contributes to the Inhibition of Cell-Cell Fusion

Open access
Roy, Nathan H., Lambelé, Marie, Chan, Jany, Symeonides, Menelaos, Thali, Markus·2014·Journal of Virology

Abstract

During cell-to-cell transmission of HIV-1, viral and cellular proteins transiently accumulate at the contact zone between infected (producer) and uninfected (target) cells, forming the virological synapse. Rearrangements of the cytoskeleton in producer and target cells are required for proper targeting of viral and cellular components during synapse formation, yet little is known about how these processes are regulated, particularly within the producer cell. Since ezrin-radixin-moesin (ERM) proteins connect F-actin with integral and peripheral membrane proteins, are incorporated into virions, and interact with cellular components of the virological presynapse, we hypothesized that they play roles during the late stage of HIV-1 replication. Here we document that phosphorylated (i.e., active) ezrin specifically accumulates at the HIV-1 presynapse in T cell lines and primary CD4 + lymphocytes. To investigate whether ezrin supports virus transmission, we sought to ablate ezrin expression in producer cells. While cells did not tolerate a complete knockdown of ezrin, even a modest reduction of ezrin expression (∼50%) in HIV-1-producing cells led to the release of particles with impaired infectivity. Further, when cocultured with uninfected target cells, ezrin-knockdown producer cells displayed reduced accumulation of the tetraspanin CD81 at the synapse and fused more readily with target cells, thus forming syncytia. Such an outcome likely is not optimal for virus dissemination, as evidenced by the fact that, in vivo , only relatively few infected cells form syncytia. Thus, ezrin likely helps secure efficient virus spread not only by enhancing virion infectivity but also by preventing excessive membrane fusion at the virological synapse. IMPORTANCE While viruses, in principal, can propagate through successions of syncytia, HIV-1-infected cells in the majority of cases do not fuse with potential target cells during viral transmission. This mode of spread is coresponsible for key features of HIV-1 pathogenesis, including killing of bystander cells and establishment of latently infected T lymphocytes. Here we identify the ERM protein family member ezrin as a cellular factor that contributes to the inhibition of cell-cell fusion and thus to suppressing excessive syncytium formation. Our analyses further suggest that ezrin, which connects integral membrane proteins with actin, functions in concert with CD81, a member of the tetraspanin family of proteins. Additional evidence, documented here and elsewhere, suggests that ezrin and CD81 cooperate to prevent cytoskeleton rearrangements that need to take place during the fusion of cellular membranes.

Integrity signals

Registry

Crossref · 10.1128/jvi.00550-14

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • During cell-to-cell transmission, HIV-1 Env-mediated fusion is inhibited by cell membrane proteins that accumulate at the VS zone: tetraspanins, ezrin, and Ewi-2.

    “However, during cell-to-cell transmission, this process is inhibited by cell membrane proteins that accumulate at the VS zone: tetraspanins [46], ezrin [47], and Ewi-2 [48].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Roy, N. H., Lambelé, M., Chan, J., Symeonides, M., & Thali, M.
Affiliations
University of Vermont (US)
Venue
Journal of Virology
Published
2014-07
Volume
88
Issue
13
Pages
7645-7658
ISSN
  • 0022-538X (ISSN-L)
  • 1098-5514
OpenAlex
W2160435529
Cited by
42
References
3
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2022: 7 · 2021: 5 · 2020: 2 · 2019: 4 · 2018: 6 · 2017: 4 · 2016: 4 · 2015: 4 · 2014: 2
FWCI
2.08
Type
journal article
Language
en
Open access
Locations
  • Journal of Virology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases (R01AI080302, T32AI055402)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords
ezrin, HIV-1, virological synapse, cell-cell fusion, syncytium formation, CD81, tetraspanins, ERM proteins, actin cytoskeleton, virus transmission, CD4+ T cells, viral infectivity, HIV latency, F-actin
MeSH terms
Ezrin, Cell Communication, Cell Fusion, Cytoskeletal Proteins, Cytoskeleton, Flow Cytometry, HeLa Cells, Humans, Phosphorylation, T-Lymphocytes, Blotting, Western, HIV-1, HIV Infections, RNA, Small Interfering, Virus Internalization, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review